<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37327212</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Changes in hospitalizations and emergency department respiratory viral diagnosis trends before and during the COVID-19 pandemic in Ontario, Canada.</ArticleTitle><Pagination><StartPage>e0287395</StartPage><MedlinePgn>e0287395</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0287395</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0287395</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Population-level surveillance systems have demonstrated reduced transmission of non-SARS-CoV-2 respiratory viruses during the COVID-19 pandemic. In this study, we examined whether this reduction translated to reduced hospital admissions and emergency department (ED) visits associated with influenza, respiratory syncytial virus (RSV), human metapneumovirus, human parainfluenza virus, adenovirus, rhinovirus/enterovirus, and common cold coronavirus in Ontario.</AbstractText><AbstractText Label="METHODS">Hospital admissions were identified from the Discharge Abstract Database and exclude elective surgical admissions and non-emergency medical admissions (January 2017-March 2022). Emergency department (ED) visits were identified from the National Ambulatory Care Reporting System. International Classification of Diseases (ICD-10) codes were used to classify hospital visits by virus type (January 2017-May 2022).</AbstractText><AbstractText Label="RESULTS">At the onset of the COVID-19 pandemic, hospitalizations for all viruses were reduced to near-trough levels. Hospitalizations and ED visits for influenza (9,127/year and 23,061/year, respectively) were nearly absent throughout the pandemic (two influenza seasons; April 2020-March 2022). Hospitalizations and ED visits for RSV (3,765/year and 736/year, respectively) were absent for the first RSV season during the pandemic, but returned for the 2021/2022 season. This resurgence of hospitalizations for RSV occurred earlier in the season than expected, was more likely among younger infants (age ≤6 months), more likely among older children (aged 6.1-24 months), and less likely to comprise of patients residing in higher areas of ethnic diversity (p&lt;0.0001).</AbstractText><AbstractText Label="CONCLUSION">During the COVID-19 pandemic, there was a reduced the burden of other respiratory infections on patients and hospitals. The epidemiology of respiratory viruses in the 2022/23 season remains to be seen.</AbstractText><CopyrightInformation>Copyright: © 2023 Habbous et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Habbous</LastName><ForeName>Steven</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9650-9105</Identifier><AffiliationInfo><Affiliation>Ontario Health (Strategic Analytics), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology &amp; Biostatistics, Western University, London, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hota</LastName><ForeName>Susy</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Vanessa G</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Ontario Health (Strategic Analytics), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Division of Infectious Diseases, University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Sinai Health/ University Health Network, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henry</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ontario Health (Strategic Analytics), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellsten</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ontario Health (Strategic Analytics), Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="Y">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>19</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37327212</ArticleId><ArticleId IdType="pmc">PMC10275476</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0287395</ArticleId><ArticleId IdType="pii">PONE-D-22-35031</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moriyama M, Hugentobler WJ, Iwasaki A. Seasonality of Respiratory Viral Infections. Annu Rev Virol. 2020;7(1):83–101. doi: 10.1146/annurev-virology-012420-022445</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-012420-022445</ArticleId><ArticleId IdType="pubmed">32196426</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh K, Perlman S, Monto A, Englund JA. A Proposal to Refer to Four Coronaviruses of Limited Human Virulence “Common Cold Coronaviruses.” J Infect Dis. 2022. Dec 13;226(12):2047–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494316</ArticleId><ArticleId IdType="pubmed">36052654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagacé-Wiens P, Bullard J, Cole R, Van Caeseele P. Seasonality of coronaviruses and other respiratory viruses in Canada: Implications for COVID-19. Can Commun Dis Rep. 2021. Mar 31;47(3):132–8. doi: 10.14745/ccdr.v47i03a02</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v47i03a02</ArticleId><ArticleId IdType="pmc">PMC8109286</ArticleId><ArticleId IdType="pubmed">34012336</ArticleId></ArticleIdList></Reference><Reference><Citation>National Respiratory and Enteric Virus Surveillance System | CDC [Internet]. [cited 2022 Oct 4]. https://www.cdc.gov/surveillance/nrevss/index.html</Citation></Reference><Reference><Citation>Moore R, Purvis RS, Hallgren E, Reece S, Padilla-Ramos A, Gurel-Headley M, et al.. “I am hesitant to visit the doctor unless absolutely necessary”: A qualitative study of delayed care, avoidance of care, and telehealth experiences during the COVID-19 pandemic. Medicine (Baltimore). 2022. Aug 12;101(32):E29439. doi: 10.1097/MD.0000000000029439</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000029439</ArticleId><ArticleId IdType="pmc">PMC9370251</ArticleId><ArticleId IdType="pubmed">35960102</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamm P, Sagoschen I, Weise K, Plachter B, Münzel T, Gori T, et al.. Influenza and RSV incidence during COVID-19 pandemic-an observational study from in-hospital point-of-care testing. Med Microbiol Immunol. 2021. Dec 1;210(5–6):277–82. doi: 10.1007/s00430-021-00720-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-021-00720-7</ArticleId><ArticleId IdType="pmc">PMC8487758</ArticleId><ArticleId IdType="pubmed">34604931</ArticleId></ArticleIdList></Reference><Reference><Citation>Varela FH, Scotta MC, Polese-Bonatto M, Sartor ITS, Ferreira CF, Fernandes IR, et al.. Absence of detection of RSV and influenza during the COVID-19 pandemic in a Brazilian cohort: Likely role of lower transmission in the community. J Glob Health. 2021;11:1–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979153</ArticleId><ArticleId IdType="pubmed">33791096</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolbert M, Spalding C, Sinaii N, Decker BK, Palmore TN, Henderson DK. Sharp decline in rates of community respiratory viral detection among NIH Clinical Center patients during the COVID-19 pandemic. Infect Control Hosp Epidemiol. 2023;44(1):62–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9021590</ArticleId><ArticleId IdType="pubmed">35177161</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A, et al.. During the COVID‐19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol. 2021. Oct 1;56(10):3106. doi: 10.1002/ppul.25582</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25582</ArticleId><ArticleId IdType="pmc">PMC8441855</ArticleId><ArticleId IdType="pubmed">34273135</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves HE, Piché-Renaud PP, Peci A, Farrar DS, Buckrell S, Bancej C, et al.. The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study. Lancet Reg Heal Am. 2021. Sep 1;1:100015. doi: 10.1016/j.lana.2021.100015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100015</ArticleId><ArticleId IdType="pmc">PMC8285668</ArticleId><ArticleId IdType="pubmed">34386788</ArticleId></ArticleIdList></Reference><Reference><Citation>van Summeren J, Meijer A, Aspelund G, Casalegno JS, Erna G, Hoang U, et al.. Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/winter? Euro Surveill. 2021. Jul 22;26(29).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8299745</ArticleId><ArticleId IdType="pubmed">34296672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023. Mar 1;21(3). doi: 10.1038/s41579-022-00807-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00807-9</ArticleId><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MHY, Xu G, Cheng F, Khalid AF. Testing surge capacity—A Canadian COVID-19 experience, Ontario’s surge capacity for the first wave. Health Policy. 2021. Oct 1;125(10):1291. doi: 10.1016/j.healthpol.2021.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2021.08.001</ArticleId><ArticleId IdType="pmc">PMC8354859</ArticleId><ArticleId IdType="pubmed">34420801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein M, Cohen H, Nemet I, Atari N, Kliker L, Fratty IS, et al.. Human metapneumovirus prevalence during 2019–2021 in Israel is influenced by the COVID-19 pandemic. Int J Infect Dis. 2022. Jul 1;120:205–9. doi: 10.1016/j.ijid.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.04.037</ArticleId><ArticleId IdType="pubmed">35472530</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institute for Health Information. Indicator Library: General Methodology Notes—Clinical Indicators [Internet]. Ottawa; 2021.</Citation></Reference><Reference><Citation>Sheehan KJ, Sobolev B, Guy P, Bohm E, Hellsten E, Sutherland JM, et al.. Constructing an Episode of Care from Acute Hospitalization Records for Studying Effects of Timing of Hip Fracture Surgery. J Orthop Res. 2016. Feb 1;34(2):197. doi: 10.1002/jor.22997</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jor.22997</ArticleId><ArticleId IdType="pmc">PMC4995103</ArticleId><ArticleId IdType="pubmed">26228250</ArticleId></ArticleIdList></Reference><Reference><Citation>Habbous S, Lambrinos A, Petersen S, Hellsten E. The effect of the COVID-19 pandemic on hospital admissions and outpatient visits in Ontario, Canada. Ann Thorac Med. 2023;18(2):70–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10263076</ArticleId><ArticleId IdType="pubmed">37323374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, et al.. Validating International Classification of Disease 10th Revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS One. 2021. Jan 1;16(1). doi: 10.1371/journal.pone.0244746</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244746</ArticleId><ArticleId IdType="pmc">PMC7790248</ArticleId><ArticleId IdType="pubmed">33411792</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson FI, Dunn JR, Smith KLW, Moineddin R, Glazier RH. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103(8 Suppl 2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6973681</ArticleId><ArticleId IdType="pubmed">23618065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospitalizations and Deaths among COVID-19 Cases in Ontario by Age: Waves 1, 2, 3, 4 and 5 [Internet]. Toronto, ON: Queen’s Printer for Ontario; 2022 [cited 2022 Jul 20]. https://www.publichealthontario.ca/-/media/documents/ncov/epi/2021/11/covid-19-hospitalizations-deaths-ontario-quick-epi-summary.pdf?sc_lang=en</Citation></Reference><Reference><Citation>Bancej C, Rahal A, Lee L, Buckrell S, Schmidt K, Bastien N. National FluWatch mid-season report, 2021–2022: Sporadic influenza activity returns. Can Commun Dis Rep. 2022;48(1):39–45. doi: 10.14745/ccdr.v48i01a06</Citation><ArticleIdList><ArticleId IdType="doi">10.14745/ccdr.v48i01a06</ArticleId><ArticleId IdType="pmc">PMC8856831</ArticleId><ArticleId IdType="pubmed">35273468</ArticleId></ArticleIdList></Reference><Reference><Citation>Weekly influenza reports [Internet]. Public Health Agency of Canada; 2022 [cited 2022 Nov 28]. https://www.canada.ca/en/public-health/services/diseases/flu-influenza/influenza-surveillance/weekly-influenza-reports.html</Citation></Reference><Reference><Citation>Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021. Aug 1;19(8):528–45. doi: 10.1038/s41579-021-00535-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00535-6</ArticleId><ArticleId IdType="pmc">PMC7982882</ArticleId><ArticleId IdType="pubmed">33753932</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TC, Sinha I, Barr IG, Zambon M. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. Eurosurveillance. 2021. Jul 7;26(29):1. doi: 10.2807/1560-7917.ES.2021.26.29.2100186</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.29.2100186</ArticleId><ArticleId IdType="pmc">PMC8299749</ArticleId><ArticleId IdType="pubmed">34296673</ArticleId></ArticleIdList></Reference><Reference><Citation>Firquet S, Beaujard S, Lobert PE, Sané F, Caloone D, Izard D, et al.. Survival of Enveloped and Non-Enveloped Viruses on Inanimate Surfaces. Microbes Environ. 2015. Jun 19;30(2):140. doi: 10.1264/jsme2.ME14145</Citation><ArticleIdList><ArticleId IdType="doi">10.1264/jsme2.ME14145</ArticleId><ArticleId IdType="pmc">PMC4462923</ArticleId><ArticleId IdType="pubmed">25843687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraay ANM, Hayashi MAL, Hernandez-Ceron N, Spicknall IH, Eisenberg MC, Meza R, et al.. Fomite-mediated transmission as a sufficient pathway: a comparative analysis across three viral pathogens. BMC Infect Dis. 2018. Oct 29;18(1). doi: 10.1186/s12879-018-3425-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3425-x</ArticleId><ArticleId IdType="pmc">PMC6206643</ArticleId><ArticleId IdType="pubmed">30373527</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, et al.. Respiratory Virus Shedding in Exhaled Breath and Efficacy of FaceMasks. Nat Med. 2020. May 1;26(5):676. doi: 10.1038/s41591-020-0843-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0843-2</ArticleId><ArticleId IdType="pmc">PMC8238571</ArticleId><ArticleId IdType="pubmed">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsey AR, Cameron A, Branche AR, Walsh EE. Perturbations in Respiratory Syncytial Virus Activity During the SARS-CoV-2 Pandemic. J Infect Dis. 2022. Dec 28;227(1):83–6. doi: 10.1093/infdis/jiac434</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac434</ArticleId><ArticleId IdType="pubmed">36315855</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenenbaum T, Doenhardt M, Diffloth N, Berner R, Armann JP. High burden of RSV hospitalizations in Germany 2021–2022. Infection. 2022. Jul 29. doi: 10.1007/s15010-022-01889-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01889-6</ArticleId><ArticleId IdType="pmc">PMC9334552</ArticleId><ArticleId IdType="pubmed">35904753</ArticleId></ArticleIdList></Reference><Reference><Citation>Koltai M, Krauer F, Hodgson D, van Leeuwen E, Treskova-Schwarzbach M, Jit M, et al.. Determinants of RSV epidemiology following suppression through pandemic contact restrictions. Epidemics. 2022. Sep 1;40. doi: 10.1016/j.epidem.2022.100614</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.epidem.2022.100614</ArticleId><ArticleId IdType="pmc">PMC9301974</ArticleId><ArticleId IdType="pubmed">35901639</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wang X, Cong B, Deng S, Feikin DR, Nair H. Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic. J Infect Dis. 2022. Mar 15;225(6):957–64. doi: 10.1093/infdis/jiab606</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab606</ArticleId><ArticleId IdType="pmc">PMC8807230</ArticleId><ArticleId IdType="pubmed">35030633</ArticleId></ArticleIdList></Reference><Reference><Citation>Billard MN, van De Ven PM, Baraldi B, Kragten-Tabatabaie L, Bont LJ, Wildenbeest JG. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures. Influenza Other Respi Viruses. 2022;16(5):926–36. doi: 10.1111/irv.12998</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12998</ArticleId><ArticleId IdType="pmc">PMC9343326</ArticleId><ArticleId IdType="pubmed">35733362</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden JS, Sikazwe C, Xie R, Deng YM, Sullivan SG, Michie A, et al.. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun. 2022. Dec;13(1):2884. doi: 10.1038/s41467-022-30485-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30485-3</ArticleId><ArticleId IdType="pmc">PMC9130497</ArticleId><ArticleId IdType="pubmed">35610217</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie PM, Reicherz F, Solimano A, Langley JM. Potential resurgence of respiratory syncytial virus in Canada. CMAJ. 2021. Jul 26;193(29):E1140–1. doi: 10.1503/cmaj.210919</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.210919</ArticleId><ArticleId IdType="pmc">PMC8321303</ArticleId><ArticleId IdType="pubmed">34312169</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Intervention Timeline in Canada | CIHI [Internet]. [cited 2022 Sep 14]. https://www.cihi.ca/en/covid-19-intervention-timeline-in-canada</Citation></Reference><Reference><Citation>Shokri A, Moradi G, Moradpour F, Mohamadi Bolbanabad A, Younesi F, Daftarifard P, et al.. Influenza incidence overlapped with COVID-19 or under COVID-19 control measures. Immunity, Inflamm Dis. 2022. Aug 1;10(8):e672. doi: 10.1002/iid3.672</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.672</ArticleId><ArticleId IdType="pmc">PMC9274801</ArticleId><ArticleId IdType="pubmed">35894708</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S, Zhang T, Lyu Y, Lai S, Dai P, Zheng J, et al.. Influenza’s plummeting during the COVID-19 pandemic: The roles of mask-wearing, mobility change, and SARS-CoV-2 interference. Eng (Beijing, China). 2023;21:195–202. doi: 10.1016/j.eng.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eng.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8808434</ArticleId><ArticleId IdType="pubmed">35127196</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatram S, Alapati A, Dileep A, Diaz-Fuentes G. Change in patterns of hospitalization for influenza during COVID-19 surges. Influenza Other Respi Viruses. 2022. Jan 1;16(1):72–8. doi: 10.1111/irv.12900</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12900</ArticleId><ArticleId IdType="pmc">PMC8653106</ArticleId><ArticleId IdType="pubmed">34427056</ArticleId></ArticleIdList></Reference><Reference><Citation>Groves HE, Papenburg J, Mehta K, Bettinger JA, Sadarangani M, Halperin SA, et al.. The effect of the COVID-19 pandemic on influenza-related hospitalization, intensive care admission and mortality in children in Canada: A population-based study. Lancet Reg Heal Am. 2022. Mar 1;7:100132. doi: 10.1016/j.lana.2021.100132</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2021.100132</ArticleId><ArticleId IdType="pmc">PMC8913102</ArticleId><ArticleId IdType="pubmed">35291567</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Aged Care | Australian Influenza Surveillance Report and Activity Updates [Internet]. [cited 2022 Sep 12]. https://www1.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-ozflu-flucurr.htm</Citation></Reference><Reference><Citation>Verma AA, Hora T, Jung HY, Fralick M, Malecki SL, Lapointe-Shaw L, et al.. Characteristics and outcomes of hospital admissions for COVID-19 and influenza in the Toronto area. CMAJ. 2021. Mar 22;193(12):E410–8. doi: 10.1503/cmaj.202795</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.202795</ArticleId><ArticleId IdType="pmc">PMC8096386</ArticleId><ArticleId IdType="pubmed">33568436</ArticleId></ArticleIdList></Reference><Reference><Citation>Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al.. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019. Dec 26;116(52):27142–50. doi: 10.1073/pnas.1911083116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1911083116</ArticleId><ArticleId IdType="pmc">PMC6936719</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro Alonso JA, Bont LJ, Bozzola E, Herting E, Lega F, Mader S, et al.. RSV: perspectives to strengthen the need for protection in all infants. Emerg Themes Epidemiol. 2021. Dec 1;18(1):vancou. doi: 10.1186/s12982-021-00104-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12982-021-00104-5</ArticleId><ArticleId IdType="pmc">PMC8529565</ArticleId><ArticleId IdType="pubmed">34674730</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmoele-Thoma B, Zareba AM, Jiang Q, Maddur MS, Danaf R, Mann A, et al.. Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study. N Engl J Med. 2022. Jun 23;386(25):2377–86. doi: 10.1056/NEJMoa2116154</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116154</ArticleId><ArticleId IdType="pubmed">35731653</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley DA, Sikazwe CT, Minney-Smith CA, Ernst T, Moore HC, Nicol MP, et al.. An Unusual Resurgence of Human Metapneumovirus in Western Australia Following the Reduction of Non-Pharmaceutical Interventions to Prevent SARS-CoV-2 Transmission. Viruses. 2022. Oct 1;14(10). doi: 10.3390/v14102135</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102135</ArticleId><ArticleId IdType="pmc">PMC9612024</ArticleId><ArticleId IdType="pubmed">36298690</ArticleId></ArticleIdList></Reference><Reference><Citation>Kivit CMHJ, Groen K, Jongbloed M, Linssen CFM, van Loo A, van Gorp ECM, et al.. An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown. J Infect. 2022. May 1;84(5):722. doi: 10.1016/j.jinf.2022.01.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.01.042</ArticleId><ArticleId IdType="pmc">PMC8847107</ArticleId><ArticleId IdType="pubmed">35123959</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley SF, Richens N, Lees E, Cregan J, Kalimeris E, Oakley S, et al.. Changes in paediatric respiratory infections at a UK teaching hospital 2016–2021; impact of the SARS-CoV-2 pandemic. J Infect. 2022. Jan 1;84(1):40–7. doi: 10.1016/j.jinf.2021.10.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.10.022</ArticleId><ArticleId IdType="pmc">PMC8591975</ArticleId><ArticleId IdType="pubmed">34757137</ArticleId></ArticleIdList></Reference><Reference><Citation>Respiratory Viruses (including influenza) | Public Health Ontario [Internet]. [cited 2022 Sep 13]. https://www.publichealthontario.ca/en/laboratory-services/test-information-index/virus-respiratory</Citation></Reference><Reference><Citation>Adlhoch C, Sneiderman M, Martinuka O, Melidou A, Bundle N, Fielding J, et al.. Spotlight influenza: The 2019/20 influenza season and the impact of COVID-19 on influenza surveillance in the WHO European Region. Euro Surveill. 2021. Oct 7;26(40). doi: 10.2807/1560-7917.ES.2021.26.40.2100077</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.40.2100077</ArticleId><ArticleId IdType="pmc">PMC8511754</ArticleId><ArticleId IdType="pubmed">34622760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>